Are you Dr. Bendapudi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 79 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
101 Nicolls Rd
Boston, MA 11794Phone+1 617-726-2862
Summary
- Dr. Pavan Bendapudi, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts and Florida. He is affiliated with Massachusetts General Hospital and is a Clinical Fellow in Pathology at Brigham and Women's Hospital.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2012 - 2015- Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Blood Banking/Transfusion Medicine, 2011 - 2012
Massachusetts General HospitalResidency, Internal Medicine, 2008 - 2011
Stanford University School of MedicineClass of 2008
Certifications & Licensure
MA State Medical License 2010 - 2025
FL State Medical License 2021 - 2023- American Board of Pathology Blood Banking/Transfusion Medicine
Publications & Presentations
PubMed
- Loss of function in protein Z (PROZ) is associated with increased risk of ischemic stroke in the UK Biobank.Amelia K Haj, Justine Ryu, Sean J Jurgens, Sharjeel Chaudhry, Satoshi Koyama
Journal of Thrombosis and Haemostasis. 2024-10-09 - Plasma kallikrein supports FXII-independent thrombin generation in mouse whole blood.Jun Wan, Sophia Dhrolia, Rohan R Kasthuri, Yuriy Prokopenko, Anton Ilich
Blood Advances. 2024-06-25 - 2 citationsThrombosis risk in single- and double-heterozygous carriers of factor V Leiden and prothrombin G20210A in FinnGen and the UK Biobank.Justine Ryu, Joel T Rämö, Sean J Jurgens, Teemu Niiranen, Simone Sanna-Cherchi
Blood. 2024-06-06
Press Mentions
Newer Blood Thinners Surpass Warfarin for Treating Seniors with Afib and Prior StrokeApril 14th, 2022- Clinicians Report Success with First Test of Drug in a Patient with Life-Threatening Blood Clotting DisorderMay 17th, 2024
- Medical Professionals See Positive Results in Initial Trial of Medication for Severe Blood Clotting DisorderMay 19th, 2024
